Ester Q4 Net Profit Jumps 301% to ₹7.9 Crore
Ester Industries reported a strong recovery in Q4 FY26, with consolidated net profit surging 301% to ₹7.9 crore and total income growing 7.2% to ₹345.1 crore. For the full year, consolidated revenue increased to ₹1,392.7 crore, though the company reported a net loss of ₹27.5 crore impacted by non-cash mark-to-market losses. Management highlighted moderating headwinds from Chinese dumping and US tariffs, improved capacity utilization, and significant growth in rPET and Specialty Polymers segments.

*this image is generated using AI for illustrative purposes only.
Ester Industries has announced the transcript of its earnings call held on 15th May 2026, discussing the audited financial results for the quarter and year ended 31st March 2026. The extract of the results was published on 15th May 2026 in Financial Express and Vir Arjun, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors had approved the results at its meeting held on 13th May 2026.
Q4 FY26 Performance Highlights
For the quarter ended 31st March 2026, the company reported a strong recovery in consolidated performance. Consolidated net profit surged to ₹7.9 crore from ₹2.0 crore in the year-ago quarter. On a standalone basis, net profit for Q4 stood at ₹4.4 crore compared to ₹12.3 crore in Q4 FY25. Consolidated total income grew 7.2% to ₹345.1 crore, while EBITDA rose 10.7% to ₹43.3 crore, with margins expanding 40 bps to 12.6%.
| Metric | Q4 FY26 | Q4 FY25 | Change |
|---|---|---|---|
| Standalone Total Income | ₹257.3 crore | ₹261.4 crore | (1.6%) |
| Standalone PAT | ₹4.4 crore | ₹12.3 crore | (64%) |
| Consolidated Total Income | ₹345.1 crore | ₹321.9 crore | 7.2% |
| Consolidated PAT | ₹7.9 crore | ₹2.0 crore | 301% |
Full Year Financial Performance
For the financial year ended 31st March 2026, the company reported a standalone net profit of ₹4.4 crore, a decrease from ₹40.5 crore in the previous year. On a consolidated basis, the company reported a net loss of ₹27.5 crore for FY26 against a net profit of ₹13.7 crore in the previous year. Consolidated revenue from operations increased 7.2% to ₹1,392.7 crore from ₹1,299.0 crore. The Board has recommended a final dividend of ₹0.25 per equity share for FY 2025-26, subject to shareholder approval.
| Metric | Standalone FY26 | Standalone FY25 | Consolidated FY26 | Consolidated FY25 |
|---|---|---|---|---|
| Revenue from Operations | ₹1,059.6 crore | ₹1,084.9 crore | ₹1,392.7 crore | ₹1,299.0 crore |
| Net Profit/(Loss) | ₹4.4 crore | ₹40.5 crore | (₹27.5 crore) | ₹13.7 crore |
Business Highlights
Management noted that the quarter marked a meaningful inflection point, with major headwinds from Chinese dumping and US trade tariffs moderating. The Directorate General of Trade Remedies (DGTR) has imposed anti-dumping duties on BOPET film imports from China and certain other countries, with formal imposition by the Ministry of Finance expected in due course. Consolidated capacity utilization for BOPET film improved to 78% in FY26 from 74% in FY25.
Sales of rPET increased by 258% to 5,325 MT, with revenue rising to ₹59.3 crore. Specialty Polymers revenue grew by 16% to ₹179.3 crore. The company has commissioned a state-of-the-art rPET extruder in Hyderabad with a capacity of 20,000 metric tons per annum. Ester Filmtech delivered an impressive performance during Q4 FY26, with capacity utilization reaching 85% compared to 59% in Q4 FY25, and total income surging 67.7% year-on-year to ₹131.7 crore.
Historical Stock Returns for Ester Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.43% | -4.47% | -0.22% | -13.97% | -37.38% | -35.01% |
How quickly could the formal imposition of anti-dumping duties by the Ministry of Finance translate into margin recovery for Ester Industries' BOPET film segment, and what utilization levels are needed to return to FY25 profitability?
With rPET sales surging 258% and the new 20,000 MTPA Hyderabad extruder now commissioned, what is the realistic revenue contribution and margin profile of the rPET business over the next 2-3 years?
Given that Ester Filmtech's capacity utilization jumped from 59% to 85% in a single quarter, can this subsidiary sustain high utilization through FY27, and what risks could reverse this momentum?


































